Alitretinoin is recommended as a possible treatment for people with severe chronic hand eczema if:
- their eczema has not improved with treatments called potent topical corticosteroids and
- standard assessments show that their eczema is severe and is affecting their quality of life.
Alitretinoin treatment should be stopped:
- as soon as the eczema has clearly improved or
- if the eczema remains severe after 12 weeks or
- if the eczema has not clearly improved after 24 weeks.
Treatment with alitretinoin should be started and monitored only by doctors who:
- are skin specialists (dermatologists) or
- have experience in both treating people with severe chronic hand eczema and using drugs like alitretinoin.
When assessing how a person’s eczema affects their quality of life, healthcare professionals should take into account any disabilities or difficulties in communicating which might mean that the standard assessments do not provide accurate information.